E31.2
Multiple endocrine neoplasia [MEN] syndromes
Clinical Classification Guidelines
Inclusion Terms
- Multiple endocrine adenomatosis
Code Also
- any associated malignancies and other conditions associated with the syndromes
Medical Intelligence & Overview
Multiple Endocrine Neoplasia (MEN) syndromes represent a group of disorders characterized by the development of tumors in multiple endocrine glands. These tumors can produce excess hormones or, in some cases, be non-functioning. The condition is inherited, meaning it can run in families, and its manifestation can vary widely among individuals. Recognizing MEN syndromes is crucial because they may lead to significant health problems if not diagnosed and managed appropriately. The term 'Multiple endocrine adenomatosis' is often used interchangeably to describe this condition, emphasizing the presence of multiple benign tumors in endocrine tissues.
Causes & Symptoms
Clinical Causes: Genetic mutations passed down from parents, most commonly mutations in the RET proto-oncogene for MEN type 2 syndromes Inherited patterns, making it a familial condition in many cases Additional, less common genetic alterations affecting other endocrine-related genes
Key Symptoms: Hormonal imbalances leading to symptoms such as hypercalcemia, high blood pressure, or irregular hormone production Tumors in glands such as the thyroid, parathyroid, adrenal glands, or pancreatic islets Swelling or lumps in affected glands Symptoms specific to the hormone overproduction, like flushing, excessive sweating, or weight changes In some cases, tumors may be asymptomatic and detected only through screening
Diagnostic & Treatment
Diagnosis Path: Diagnosing MEN syndromes involves a combination of approaches including analyzing family health history, blood tests to measure hormone levels, imaging studies such as ultrasound, MRI, or CT scans to identify tumors, and genetic testing to detect specific mutations. Regular screening and early detection are vital since they can help prevent or manage serious complications associated with hormone-secreting tumors and their effects.
Treatment Protocols: Management of MEN syndromes typically includes surgical removal of tumors, medications to control hormone levels, and targeted therapies for malignant tumors if they develop. Ongoing surveillance is essential after initial treatment to monitor for tumor recurrence or the emergence of new tumors. A multidisciplinary team of healthcare professionals guides the personalized treatment plan tailored to each patient's specific type and severity of the syndrome.
Clinical Advice & FAQs
Billing Guidance
Is E31.2 a billable ICD-10 code?
Yes, E31.2 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E31.2?
Clinical documentation must specify the nature of Multiple endocrine neoplasia [MEN] syndromes and any associated comorbidities for accurate reporting.
Cite this Clinical Reference